Senior Manager, EXM BIO Supply Chain VPT Lead at Bristol-Myers Squibb

New Brunswick, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Experience in supply chain management, particularly in pharmaceutical or biotech environments interfacing with CMOs (Contract Manufacturing Organizations)
Strong relationship-building skills with external CMO counterparts and internal stakeholders
Ability to lead supply chain-related meetings and participate in Virtual Plant Team (VPT), CMO, and BMS Supply Chain meetings
Proficiency in metrics reporting, forecasting review, and action item generation for performance improvement
Knowledge of supply priorities determination, capacity constraints management, and risk mitigation
Expertise in handling change controls, back orders, supply delays, quality events, and new SKU introductions
Effective communication and escalation skills across ExM and Global Supply Chain teams

Responsibilities

Maintaining/developing strong relationships with supply chain counterparts at CMOs and internal BMS stakeholders to facilitate continuous performance improvement
Participate in Virtual Plant team meetings, CMO face-to-face meetings, and lead supply chain-related meetings with CMO as required
Participate in BMS Supply Chain meetings as required to ensure alignment on BMS customer requirements
Serve as point of escalation for other Supply Chain functions including ExM Customer Planning, ExM Planning, ExM Logistics, Market Supply Planning, and Inventory Control teams
Prepare Supply Chain-related topics for discussion at CMO business reviews and represent BMS Supply Chain at relevant business reviews
Accountable for CMO supply chain metrics; report metrics to CMO, VPT, and within ExM Supply Chain; generate action items to resolve performance below target
Review relevant CMO forecasts for significant changes, communicate major changes and background to VPT and CMO, and communicate forecasts to CMO
Determine supply priorities through interaction with wider ExM and Global Supply Chain teams and communicate these to the CMO
Understand supplier capacity constraints in short, medium, and long term; aid resolution and escalate to VPT and BMS Supply Chain Management as necessary
Hold VPT accountable for continuity of supply and mitigation of risk to customers
Communicate inventory risks to ExM inventory control and finance teams in a timely manner
For finished goods, support ExM Supply Chain with new SKU introduction (line extensions) to meet market requirements
Review CMO-related change controls to understand supply chain impact, assign relevant child actions, engage with ExM planning teams to manage/mitigate supply restrictions, and align with Global Planning
Proactively aid in mitigation of Back Orders and Anticipated Back Orders with relevant CMO to ensure continuity of supply
Communicate and coordinate activities to determine impact of supply delays, quality events, line shutdowns, projects (e.g., Serialization) on supply to customers; engage with other Supply Chain functions and mitigate impacts
Effectively communicate, escalate, manage relevant stakeholders, and implement standard ExM communication tools

Skills

Supply Chain Management

CMO Management

Stakeholder Management

Performance Improvement

Supply Planning

Logistics

Inventory Control

Business Reviews

Virtual Plant Team

Escalation Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free